FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113936489> ?p ?o ?g. }

• W2113936489 endingPage "4433" @default.
• W2113936489 startingPage "4425" @default.
• W2113936489 abstract "Pancreatic neuroendocrine tumors (PNETs), although rare, often metastasize, such that surgery, the only potentially curative therapy, is not possible. There is no effective systemic therapy for patients with advanced PNETs. Therefore, new strategies are needed. Toward that end, we investigated the potential benefit of dual therapeutic targeting of the epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) kinases, using a preclinical mouse model of PNET.Rapamycin and erlotinib, inhibitors of mTOR and EGFR, respectively, were used to treat RIP-Tag2 transgenic mice bearing advanced multifocal PNET. Tumor growth and survival were monitored, and tumors were surveyed for potential biomarkers of response to the therapeutics.Rapamycin monotherapy was notably efficacious, prolonging survival concomitant with tumor stasis (stable disease). However, the tumors developed resistance, as evidenced by eventual relapse to progressive tumor growth. Erlotinib monotherapy slowed tumor growth and elicited a marginal survival benefit. In combination, there was an unprecedented survival benefit in the face of this aggressive multifocal cancer and, in contrast to either monotherapy, the development of adaptive resistance was not apparent. Additionally, the antiapoptotic protein survivin was implicated as a biomarker of sensitivity and beneficial responses to the dual targeted therapy.Preclinical trials in a mouse model of endogenous PNET suggest that combined targeting of the mTOR and EGFR signaling pathways could have potential clinical benefit in treating PNET. These results have encouraged development of an ongoing phase II clinical trial aimed to evaluate the efficacy of this treatment regimen in human neuroendocrine tumors." @default.
• W2113936489 created "2016-06-24" @default.
• W2113936489 creator A5007537368 @default.
• W2113936489 creator A5066247828 @default.
• W2113936489 creator A5089842877 @default.
• W2113936489 date "2010-10-10" @default.
• W2113936489 modified "2023-10-16" @default.
• W2113936489 title "Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis" @default.
• W2113936489 cites W1918156452 @default.
• W2113936489 cites W1970852630 @default.
• W2113936489 cites W1972486056 @default.
• W2113936489 cites W1983683808 @default.
• W2113936489 cites W1985934694 @default.
• W2113936489 cites W2000110198 @default.
• W2113936489 cites W2008504821 @default.
• W2113936489 cites W2015793629 @default.
• W2113936489 cites W2015809080 @default.
• W2113936489 cites W2016595672 @default.
• W2113936489 cites W2027636023 @default.
• W2113936489 cites W2029225165 @default.
• W2113936489 cites W2034548257 @default.
• W2113936489 cites W2035521247 @default.
• W2113936489 cites W2035523654 @default.
• W2113936489 cites W2043548519 @default.
• W2113936489 cites W2049012147 @default.
• W2113936489 cites W2053219638 @default.
• W2113936489 cites W2057919501 @default.
• W2113936489 cites W2064193831 @default.
• W2113936489 cites W2066217014 @default.
• W2113936489 cites W2066303541 @default.
• W2113936489 cites W2067175668 @default.
• W2113936489 cites W2071394735 @default.
• W2113936489 cites W2085739690 @default.
• W2113936489 cites W2089723533 @default.
• W2113936489 cites W2094672247 @default.
• W2113936489 cites W2102148658 @default.
• W2113936489 cites W2106988387 @default.
• W2113936489 cites W2110825909 @default.
• W2113936489 cites W2112064092 @default.
• W2113936489 cites W2112130045 @default.
• W2113936489 cites W2119492915 @default.
• W2113936489 cites W2124064187 @default.
• W2113936489 cites W2125561041 @default.
• W2113936489 cites W2125887187 @default.
• W2113936489 cites W2126783165 @default.
• W2113936489 cites W2128267006 @default.
• W2113936489 cites W2130348457 @default.
• W2113936489 cites W2132299300 @default.
• W2113936489 cites W2138081106 @default.
• W2113936489 cites W2140238752 @default.
• W2113936489 cites W2145392262 @default.
• W2113936489 cites W2148346100 @default.
• W2113936489 cites W2149296859 @default.
• W2113936489 cites W2157824687 @default.
• W2113936489 cites W2158134441 @default.
• W2113936489 cites W2160531384 @default.
• W2113936489 cites W2160573271 @default.
• W2113936489 cites W2164109910 @default.
• W2113936489 cites W2184718406 @default.
• W2113936489 cites W2587683551 @default.
• W2113936489 doi "https://doi.org/10.1200/jco.2010.28.0198" @default.
• W2113936489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3041788" @default.
• W2113936489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20823411" @default.
• W2113936489 hasPublicationYear "2010" @default.
• W2113936489 type Work @default.
• W2113936489 sameAs 2113936489 @default.
• W2113936489 citedByCount "95" @default.
• W2113936489 countsByYear W21139364892012 @default.
• W2113936489 countsByYear W21139364892013 @default.
• W2113936489 countsByYear W21139364892014 @default.
• W2113936489 countsByYear W21139364892015 @default.
• W2113936489 countsByYear W21139364892016 @default.
• W2113936489 countsByYear W21139364892017 @default.
• W2113936489 countsByYear W21139364892018 @default.
• W2113936489 countsByYear W21139364892019 @default.
• W2113936489 countsByYear W21139364892020 @default.
• W2113936489 countsByYear W21139364892021 @default.
• W2113936489 countsByYear W21139364892022 @default.
• W2113936489 countsByYear W21139364892023 @default.
• W2113936489 crossrefType "journal-article" @default.
• W2113936489 hasAuthorship W2113936489A5007537368 @default.
• W2113936489 hasAuthorship W2113936489A5066247828 @default.
• W2113936489 hasAuthorship W2113936489A5089842877 @default.
• W2113936489 hasBestOaLocation W21139364892 @default.
• W2113936489 hasConcept C121608353 @default.
• W2113936489 hasConcept C126322002 @default.
• W2113936489 hasConcept C143998085 @default.
• W2113936489 hasConcept C2777506169 @default.
• W2113936489 hasConcept C2778087573 @default.
• W2113936489 hasConcept C2779066768 @default.
• W2113936489 hasConcept C2779438470 @default.
• W2113936489 hasConcept C2781230642 @default.
• W2113936489 hasConcept C502942594 @default.
• W2113936489 hasConcept C55493867 @default.
• W2113936489 hasConcept C62478195 @default.
• W2113936489 hasConcept C71924100 @default.
• W2113936489 hasConcept C86554907 @default.
• W2113936489 hasConcept C86803240 @default.

• next